Alzheimer’s
Keeping tabs on pharma: Clinical trials on pause in Russia
March 16 by Leila HawkinsIn Pharma IQ’s latest news round-up: Clinical trials pause in Russia but medical supplies will continue
Keeping tabs on pharma: Viagra-like drug shows promise in treating dementia
February 15 by Leila HawkinsNew research finds that a drug related to sildenafil could help treat dementia
Innovative Therapies for Alzheimer’s Disease
September 26 by Pharmaceuticals & Biotechnology EditorIn the US alone, Alzheimer’s disease healthcare costs are projected to increase from $200 billion in 2013 to $1.2 trillion by 2050. Thus, the lack of good treatment options for AD creates a he...